Neuroendocrine Carcinoma of the Bladder
Also known as: Bladder Neuroendocrine Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16412 | Adebrelimab | 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 / 3 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 / 3 | Recruiting | 1 |
| DB00773 | Etoposide | 2 / 3 | Recruiting | 1 |
| DB15043 | Toripalimab | 2 / 3 | Recruiting | 1 |